Hasil Pencarian - Hakan Akbulut

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors

    The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors oleh F. Gizem Sonugür, F. Gizem Sonugür, Hakan Akbulut, Hakan Akbulut

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas

    The Clinical Value of Flow Cytometric DNA Content Analysis in Patients with Soft Tissue Sarcomas oleh Mustafa Samur, Ali Pamir, Hakan Akbulut, Selim Erekul, Yener Sağlik, Yusuf Yildiz, Dilek Dinçol, Fikri Içli

    Diterbitkan 1999-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Risk factors for thrombosis risk in patients with cancer

    Risk factors for thrombosis risk in patients with cancer oleh Dilara Turan, Hatime Arzu Yasar, Ozge Bas Aksu, Elif Berna Koksoy, Gungor Utkan, Hakan Akbulut, Yuksel Urun

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    IgA lambda oligoclonal gammopathy in multiple myeloma

    IgA lambda oligoclonal gammopathy in multiple myeloma oleh İbrahim Tek, Dilsa Mızrak, Güngör Utkan, Selami Koçak Toprak, Hüseyin Tutkak, Abdullah Büyükçelik, Bülent Yalçın, Hakan Akbulut, Fikri İçli

    Diterbitkan 2010-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    IgA lambda oligoclonal gammopathy in multiple myeloma

    IgA lambda oligoclonal gammopathy in multiple myeloma oleh İbrahim Tek, Dilsa Mızrak, Güngör Utkan, Selami Koçak Toprak, Hüseyin Tutkak, Abdullah Büyükçelik, Bulent Yalçın, Hakan Akbulut, Fikri İçli

    Diterbitkan 2010-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE ON 110 PATIENTS

    P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SING... oleh Guldane Cengiz Seval, Ekin Kircali, Derya Koyun, Bulent Karakaya, Hulya Yilmaz, Gul Yavuz, Hakan Akbulut, Selami Kocak Toprak, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

    Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study oleh Abdul Rahman Jazieh, Hakan Akbulut, Giuseppe Curigliano, Alvaro Rogado, Abdullah Ali Alsharm, Evangelia D. Razis, Layth Mula-Hussain, Hassan Errihani, Adnan Khattak, Roselle B. De Guzman, Clarissa Mathias, Mohammad Omar Farouq Alkaiyat, Hoda Jradi, Christian Rolfo

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

    Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PA... oleh Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients

    Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients oleh Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: